Accelerate Diagnostics Investor Relations Material
Latest events
Q3 2024
Accelerate Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Accelerate Diagnostics Inc
Access all reports
Accelerate Diagnostics, Inc. (Accelerate), an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company's diagnostic platform utilizes its proprietary sandwich immunoassay technology to develop and commercialize assays that support the detection of clinically important viruses and bacteria associated with serious human diseases. Accelerate has developed a pipeline of diagnostic tests, including Carbapenemase (KPC) Nares Panel Kit; Meningitis Panel Kit; and Ebola Quick Test.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
AXDX
Country
πΊπΈ United States